ARTAL INTERNATIONAL SA 13D/13G Filings for Leap Therapeutics, Inc. (LPTX)

ARTAL INTERNATIONAL SA 13D and 13G filings for Leap Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
06:30 am
Purchase		 2021-12-31 13G Leap Therapeutics, Inc.
LPTX		 ARTAL INTERNATIONAL SA 400,000
4.500%		 100,000increase
(+33.33%)		 Filing
2021-02-12
9:06 pm
Unchanged		 2020-12-31 13G Leap Therapeutics, Inc.
LPTX		 ARTAL INTERNATIONAL SA 300,000
5.000%		 0
(Unchanged)		 Filing
2020-12-28
4:31 pm
Purchase		 2020-12-18 13G Leap Therapeutics, Inc.
LPTX		 ARTAL INTERNATIONAL SA 300,000
5.000%		 300,000increase
(New Position)		 Filing